Remarkably long-lasting tachyphylaxis of pain responses to ET-1: evidence against central nervous system involvement.
Remarkably long-lasting tachyphylaxis of pain responses to ET-1: evidence against central nervous system involvement.
复制标题
对 ET-1 疼痛反应的显着持久的快速耐受:反对中枢神经系统参与的证据。
DOI:
10.1139/y10-044
复制
发表时间:
2010
影响因子:
2.1
通讯作者:
Strichartz,GaryR
中科院分区:
文献类型:
--
作者:
Khodorova,Alla;Strichartz,GaryR
A profound tachyphylaxis of the acute nocifensive flinching (pain) response to subcutaneous injection of endothelin-1 (ET-1) into the hind paw footpad is shown by the reduced response to a second injection. Flinching from the second injection was 20% ± 5%, 57% ± 18%, 79% ± 35%, and 100% ± 17% of that from the first injection (both 200 µmol/L, 2 nmol) at respective intervals of 24, 30, 48, and 72 h. Inhibition of afferent impulses by local anesthesia of the sciatic nerve, reducing initial flinching to 6%–13% of control, did not affect the tachyphylaxis for the second injection at 24 h. There was no cross-desensitization between formalin and ET-1 injected sequentially into the same paw. Suppression of descending inhibitory effects from endogenous opiates by naloxone (5–8 mg/kg, i.p.), given 30 min before the second ET-1 injection, did not prevent tachyphylaxis. Diffuse effects caused by an initial subcutaneous ET-1 injection into the tail or forepaw resulted in sensitization of the response to ET-1 in the hind paw, rather than tachyphylaxis. In contrast, selective inhibition of local ETAreceptors during the initial administration of ET-1, by the antagonist BQ-123 (3.2 mmol/L), reduced tachyphylaxis of nocifensive flinching. Therefore, prolonged pain tachyphylaxis is not due to reduced responsiveness of the CNS, but rather depends on the functional sensitivity or availability of peripheral ETAreceptors.